The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 254-260

  Braga, P C ^a   Culici, M ^a   Sasso, M Dal ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Erythromycin; M phenotype and inducible resistance; Microbiological impedance measurement; Post antibiotic effect (PAE); Rokitamycin; Streptococcus pyogenes

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; MACROLIDE; ROKITAMYCIN; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MIOKAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; IMPEDANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; TIME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ELECTRIC IMPEDANCE; ERYTHROMYCIN; MIOCAMYCIN; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 4344654763     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.031     Document Type: Article

References (47)

1. Baquero F., Culebras E., Patron C., Perez-Diaz J.C., Medano J.C., Vicente M.F. Postantibiotic effect of imipenem on Gram-positive and Gram-negative micro-organisms. J Antimicrob Chemother. 18(Suppl E):1986;47-59
2. Odenholt-Tornqvist I., Bengtsson S. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations of sparfloxacin of Gram-negative bacteria. Chemotherapy. 40:1994;30-36
3. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. 3rd ed. Baltimore, MD: The Williams & Wilkins Co.; 1991. p. 403-31.
4. Mackenzie F.M., Gould I.M., Chapman D.G., Jason D. Postantibiotic effect of meropenem on members of the family Enterobacteriaceae determined by five methods. Antimicrob Agents Chemother. 38:1994;2583-2589
5. Spangler S.K., Lin G., Jacobs M.R., Appelbaum P.C. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of oxfloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrob Agents Chemother. 42:1998;1253-1255
6. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore, MD: The Williams & Wilkins Co.; 1996. p. 296-329.
7. Minguez F., Ramos C., Lascos A., Chin M.L., Prieto J. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. Chemotherapy. 39:1993;163-168
8. Pruul H., Wetherall B., McDonald P. In vitro killing of erythromycin-exposed group of streptococci by polymorphonuclear leukocytes. Eur J Clin Microbiol. 5:1986;405-410
9. Ramadan M.A., Tawfik A.F., Shibl Am., Gemmel C.G. Postantibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. J Med Microbiol. 42:1995;362-366
10. Dornbusch K., Olofsson C., Holm S. Postantibiotic effect and postantibiotic sub-MIC effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria. APMIS. 107:1999;505-513
11. Jason A.C., MacKenzie F.M., Jason D., Gould I.M. Automatic procedures for measuring post-antibiotic effect and determining random errors. J Antimicrob Chemother. 34:1994;669-678
12. Harris C.M., Kell D.B. The estimation of microbial mass. Biosensor. 1:1985;17-84
13. Hause L.L., Komorowski R.A., Gayon F. Electrode and electrolyte impedance in the detection of bacterial growth. IEEE Trans. Biomed. Eng. 28:1981;403-410
14. Felice C.J., Clavin O.E., Gallo B.V., Arnayoz M.R., Spinelli J.C., Valentinuzzi M.E. Impedancimetric bacterial detection: theoretical and experimental aspects. Med Prog Through Technol. 14:1988;25-33
15. Felice C.J., Valentinuzzi M.E. Medium and interface components in impedance microbiology. IEEE Trans. Biomed. Eng. 46:1999;1483-1487
16. Madrid R.E., Felice C.J., Valentinuzzi M.E. Automatic on-line analyses of microbial growth using simultaneous measurements of impedance and turbidity. Med Biol Eng Comput. 37:1999;789-793
17. Felice C.J., Madrid R.E., Olivera J.M., Rotger V.I., Valentinuzzi M.E. Impedance microbiology: quantification of bacterial content in milk by means of capacitance growth curves. J Microbiol Meth. 35:1999;37-42
18. Gould I.M., Jason A.C., Mitre K. Use of Malthus microbial growth analyses to study the post-antibiotic effect of antibiotics. J Antimicrob Chemother. 24:1989;523-531
19. Lowdin E., Odenholt-Tornqvist I., Bengstsson S., Cars O. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob Agents Chemother. 37:1993;2200-2205
20. MacKenzie F.M., Gould I.M., Chapman D.G., Jason D. Comparison of methodologies used in assessing the postantibiotic effect. J Antimicrob Chemother. 34:1994;223-230
21. Jason A.C., MacKenzie F.M., Jason D., Gould I.M. Automatic procedures for measuring post-antibiotic effect and determining random errors. J Antimicrob Chemother. 34:1994;669-678
22. Webster C., Ghazanfar K., Slack R. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus. J Antimicrob Chemother. 22(Suppl B):1988;33-39
23. Braga P.C., Bovio C., Culici M., Dal Sasso M. Flow cytometric assessment of susceptibilities of Streptococcus pyogenes to erythromycin and rokitamycin. Antimicrob Agents Chemother. 47:2003;408-412
24. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Road J., Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determination. Antimicrob Agents Chemother. 43:1999;2823-2830
25. Giovanetti E., Montanari M.P., Mingoia M., Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducible resistant strains. Antimicrob Agents Chemother. 47:1999;1935-1940
26. Kuenzi B., Segessemann C., Gerber A.U. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected Gram-positive bacteria and Haemophilus influenzae. J Antimicrob Chemother. 20(Suppl B):1987;39-46
27. Wawerla M., Stolle A., Schalch B., Eisgruber H. Impedance microbiology: applications in food hygiene. J Food Prot. 62:1999;1488-1496
28. Daikos G.K. Continuouis versus discontinuous antibiotic therapy: the role of the post-antibiotic effect and other factors. J Antimicrob Chemother. 27:1991;157-160
29. Leggett J.E., Fantin B., Ebert S., Totsuka K., Vogelman B., Calame W., Mattie H., Craig W.A. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis. 159:1989;281-292
30. Odenholt-Tornqvist I., Löwdin E., Cars O. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithomycin and azithromycin on respiratory tract pathogens. Antimicrob Agents Chemother. 39:1995;221-226
31. Debbia E.A., Molinari G., Paglia P., Schito G.C. Postantibiotic effect of azithromycin on respiratory tract pathogens. Drugs Exptl Clin Res. 16:1990;615-619
32. Champney W.S., Tober C.L. Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. Antimicrob Agents Chemother. 43:1999;1324-1328
33. Schito G.C., Debbia E.A., Marinelli S. Secondo progetto Artemis Italia (1998). 5. Discussione e conclusioni. Giorn Ital Microbiol Med Odont Clin. 3(QII):1999;28-41
34. Braga P.C. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14-15 membered ring macrolides. J Chemother. 14:2002;115-131
35. Capobianco I.O., Goldman R.C. Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force. Antimicrob Agent Chemother. 34:1990;1787-1791
36. 3H ]-erythromycin binding to Staphylococcus aureus Biochem Pharmacol. 35:1986;1001-1104
37. Mao J.C.H., Putterman M. Accumulation in Gram-positive and Gram-negative bacteria as a mechanism of resistance to erythromycin. J Bacteriol. 95:1968;111-117
38. 14C ) erythromycin uptake into Staphylococcus aureus Relation to antimicrobial activity. Zbl Bakt Hyg. A265:1987;393-403
39. Goldman R.C., Zakula D., Flamm R., Beyer J., Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother. 38:1994;1496-1500
40. Muto Y., Bandoh K., Watanabe K., Katoh N., Ueno K. Macrolide accumulation by Bacteroides fragilis ATCC 25285. Antimicrob Agents Chemother. 33:1989;242-244
41. Wildfeuer A., Lemme J.D. Zur pharmakokinetik von Josamycin. Arzneim Forsch/Drug Res. 35:1985;639-643
42. Inoue M, Okubo T, Hashimoto H. In vitro antibacterial activity of new macrolide antibiotic, rokitamycin. 28th ICAAC #904; 1988.
43. Endou K., Matsuoka M., Taniguchi H., Nakajama Y. Implication of cohesive binding of a macrolide antibiotic, rokitamycin, to ribosomes from Staphylococcus aureus. J Antibiot. 46:1993;478-485
44. Endou K., Matsuoka M., Nakajima Y. Adhesive binding of rokitamycin to Staphylococcus aureus ribosomes. FEMS Microbiol Lett. 72:1990;93-96
45. Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 40:1996;1817-1824
46. Luna V.A., Coates P., Eady E.A., Cove J., Nguyen T.T.H., Roberts M.C. A variety of Gram-positive bacteria carry mobile mef genes. J Antimicorb Chemother. 44:1999;19-25
47. Leclercq R, Courvalin P. Mechanisms of resistance to macrolides and functionally related antibiotics. In: Bryskier AJ, Butzler JP, Neu HC, Tulkens PM, editors. Macrolides: chemistry, pharmacology and clinical uses. Oxford: Arnette Blackwell; 1993. p. 115-23.